Emerging research indicates a robust, replicable association between joint hypermobility (including Ehlers-Danlos syndromes [EDS] and hypermobility spectrum disorders [HSD]) and several psychiatric conditions, particularly attention-deficit/hyperactivity disorder (ADHD) and depression. However, current evidence supports correlation rather than causation, with multiple plausible mechanisms including shared genetic liability, neurodevelopmental overlap, autonomic dysregulation, and the psychological burden of chronic somatic symptoms likely contributing to the observed comorbidity.
Key Empirical Findings
1. ADHD and Generalized Joint Hypermobility (GJH)
Glans et al. (2021) conducted a cross-sectional case–control study in Sweden comparing 431 adults with ADHD to 417 non-ADHD controls. Generalized joint hypermobility was assessed via physical examination using the Beighton scoring system, with additional data on musculoskeletal symptoms and cutaneous features to identify a symptomatic hypermobility phenotype.
- Adults with ADHD had significantly elevated odds of GJH: adjusted odds ratio (OR) 4.7(95% CI 3.0–7.2).
- When GJH was accompanied by musculoskeletal and/or dermatological symptoms (suggestive of HSD/hEDS), the association strengthened: adjusted OR 6.9 (95% CI 4.1–11.9).
This study is notable for starting from an ADHD cohort and examining joint hypermobility directly, reducing the likelihood that findings reflect solely surveillance bias in EDS clinics. Nevertheless, the cross-sectional design precludes causal inference.
Glans et al. (2022) extended this work to autism spectrum disorder (ASD), finding a similar pattern: ASD was associated with GJH (adjusted OR 3.1, 95% CI 1.9–5.2) and more strongly with symptomatic GJH (adjusted OR 4.9, 95% CI 2.6–9.0). Subgroup analyses suggested that comorbid ADHD might partly drive the ASD–GJH association, underscoring the need for careful phenotypic stratification.
2. EDS/Hypermobility Syndrome and Psychiatric Disorders (Including ADHD and Depression)
Cederlöf et al. (2016) used Swedish national registers to conduct a nationwide, population-based matched cohort study. They identified 1,771 individuals with EDS and 10,019 with hypermobility syndrome, along with matched controls and sibling cohorts.
- ADHD:
- EDS: 4.3% vs 0.8% in controls; relative risk (RR) 5.6 (95% CI 4.2–7.4).
- Hypermobility syndrome: 3.0% vs 0.5%; RR 5.8 (95% CI 5.0–6.7).
- Depression:
- EDS: 11.1% vs 3.6%; RR 3.4 (95% CI 2.9–4.1).
- Hypermobility syndrome: 7.0% vs 3.2%; RR 2.3 (95% CI 2.1–2.5).
Crucially, siblings of individuals with EDS (who did not necessarily have EDS themselves) also showed elevated risks: ADHD RR 2.1 (95% CI 1.4–3.3); depression RR 1.5 (95% CI 1.1–1.8). Similar, albeit attenuated, patterns were observed in siblings of those with hypermobility syndrome. These findings implicate shared familial (genetic and/or early environmental) factors in the psychiatric comorbidity, arguing against a simple model in which joint laxity alone causes ADHD or depression.
3. Systematic Review Evidence
Kennedy et al. (2022) systematically reviewed psychiatric burden in EDS, identifying 23 studies (12,298 participants) published between 2011 and 2021. The included literature was methodologically heterogeneous (cross-sectional studies, case reports, chart reviews, cohort and case–control designs).
- Depression was examined in 12 studies; anxiety in 9; neurodevelopmental disorders (including ADHD) in 7.
- The highest individual-study prevalence estimates reported were: ADHD 52.4%, anxiety 51.2%, depression 30.2%.
These figures represent upper bounds from specific samples rather than pooled prevalence estimates, and the authors emphasized the need for more rigorous, standardized research to clarify mechanisms.
4. Longitudinal Evidence in Adolescents
Eccles et al. (2022) analyzed data from the Avon Longitudinal Study of Parents and Children (ALSPAC) to test whether GJH in early adolescence predicts later depression and anxiety.
- GJH at age 14 was associated with depression at age 18 (OR 1.70, 95% CI 1.31–2.22), with a significant interaction by sex: the effect was significant in males (OR 2.10, 95% CI 1.17–3.76) but not females.
- Resting heart rate at age 14 mediated the GJH–depression relationship in males, suggesting autonomic dysregulation as a potential pathway.
- Symptomatic hypermobility (operationalized as GJH plus chronic widespread pain) at age 18 was associated with both depression (adjusted OR 3.53, 95% CI 1.67–7.40) and anxiety (adjusted OR 3.14, 95% CI 1.52–6.46).
This longitudinal design provides rare evidence that hypermobility may precede and contribute to later mood symptoms, at least in some subgroups, and highlights autonomic and pain-related mechanisms as plausible contributors.
Interpretive Framework
The converging evidence supports several non-mutually exclusive hypotheses:
- Shared Genetic/Developmental Liability
Familial aggregation of both hypermobility and psychiatric conditions (as shown in sibling analyses) suggests overlapping genetic or early developmental risk factors. - Neurodevelopmental Overlap
ADHD, ASD, and hypermobility may share underlying neurodevelopmental vulnerabilities, potentially involving connective tissue biology, proprioceptive processing, and sensorimotor integration. - Autonomic Dysregulation
Hypermobility is frequently associated with dysautonomia (e.g., postural tachycardia syndrome), which overlaps phenomenologically with anxiety and may contribute to mood dysregulation via altered interoceptive signaling. - Chronic Somatic Burden
Pain, fatigue, functional limitations, and medical uncertainty associated with symptomatic hypermobility can plausibly contribute to secondary depression and anxiety. - Surveillance and Diagnostic Bias
Individuals with EDS/HSD have greater healthcare contact, potentially increasing detection of psychiatric conditions; however, sibling data and population-based designs mitigate but do not eliminate this concern.
Limitations of Current Evidence
- Observational Designs: All key studies are observational (cross-sectional, cohort, or registry-based); none establish causal mechanisms.
- Phenotypic Heterogeneity: EDS, HSD, and GJH are spectrum conditions with variable clinical expression; psychiatric comorbidities likewise vary widely.
- Measurement Issues: Hypermobility assessment methods (Beighton score, 5-part questionnaire) and psychiatric ascertainment (self-report, registry codes, structured interviews) differ across studies, complicating comparisons.
- Sex Differences: Hypermobility is more prevalent in females, whereas some neurodevelopmental conditions are more frequently diagnosed in males; sex-specific effects (e.g., in Eccles et al.) require further investigation.
Conclusion
Current literature robustly demonstrates that ADHD and depression occur at elevated rates in individuals with hypermobility-related conditions, including EDS, HSD, and generalized joint hypermobility. However, the relationship is not unidirectional or purely causal. Instead, it likely reflects a complex interplay of shared genetic/developmental factors, neurobiological mechanisms (including autonomic and sensorimotor pathways), and the psychological impact of chronic somatic symptoms.
Future research should prioritize:
- Longitudinal designs beginning in childhood to clarify temporal relationships.
- Mechanistic studies integrating connective tissue biology, neuroimaging, and autonomic phenotyping.
- Careful phenotypic stratification (e.g., symptomatic vs asymptomatic hypermobility; ADHD with/without ASD) to identify distinct subgroups.
Until such evidence emerges, clinical practice should recognize the association without inferring causation, and consider integrated, biopsychosocial approaches to assessment and management.
Mulberry Whale PTM & Corrective Exercise 